Last updated: December 26, 2024
Sponsor: Wake Forest University Health Sciences
Overall Status: Active - Recruiting
Phase
4
Condition
Urinary Tract Infections
Treatment
Next Gen
Antibiotic
Clinical Study ID
NCT05206500
IRB00073565
Ages 18-80 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Female at least 18 years of age
U/C (Urinary Culture) growth of <10,000 Colony-Forming Units (CFU)
Understanding and acceptance of the need to return for all scheduled follow-upvisits
Able to give informed consent
Exclusion
Exclusion Criteria:
Catheter in use (Foley or suprapubic or intermittent)
Not able to provide clean midstream urine
Antibiotic consumption in the past 2 weeks before signing the consent
Pregnant or Planning to Conceive
Incarcerated
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Next Gen
Phase: 4
Study Start date:
May 17, 2022
Estimated Completion Date:
December 31, 2026
Study Description
Connect with a study center
Wake Forest Health Sciences
Winston-Salem, North Carolina 27157
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.